Safety and Tolerability of Escalating Doses of House Dust Mite- Peptide Antigen Desensitization (HDM-PAD)

First Page		Document Content
Date: 2015-11-05 09:21:27 Allergology Immunology Immune system RTT Type I hypersensitivity Allergen immunotherapy Allergen Allergic conjunctivitis Allergic rhinitis Immunoglobulin E Allergy Rhinitis		Safety and Tolerability of Escalating Doses of House Dust Mite- Peptide Antigen Desensitization (HDM-PAD) Add to Reading List Source URL: www.circassia.com Download Document from Source Website File Size: 43,28 KB Share Document on Facebook

	ZL000_00_032e_WL Guidance document Authorisation of allergen product HMV4 DocID: 1xVwb - View Document
	PDF Document DocID: 1xLBa - View Document
	PDF Document DocID: 1xvn7 - View Document
	PDF Document DocID: 1wMYP - View Document
	PDF Document DocID: 1vJ1L - View Document